PTHrP treatment improved acquisition of bone mass and strength in these mice, suggesting that using PTHrP to regulate sclerostin could be an important therapeutic strategy for maintaining bone health in diabetes. The gene discussed is PTHLH; the disease is diabetes mellitus.